Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hep-3B |
Human hepatocellular carcinoma cell line | ATCC HB-8064 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
Hep-G2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | T. H. Pham et al., J. Virol., Mar 2013; 87: 3076 - 3086 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | H.-S. Kwon et al., Diabetes, Apr 2004; 53: 899 - 910 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | M.-H. Tai et al., Mol. Nutr. Food Res., 2014, 58: 2133-2145 DOI 10.1002/mnfr.201400366 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | V. Le Fourn et al., Cell. Mol. Life Sci., 2013, 70: 1985-2002, DOI: https://doi.org/10.1007/s00018-012-1236-6 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | A. Seifert, Dissertation, 2007, Martin-Luther-Universität | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | V. C. Sladky et al., Developmental Cell, 2020, 52: 335–349, doi.org/10.1016/j.devcel.2019.12.016 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | F. Damiano et al., Biochim. et Biophys. Acta, 2015, 1849: 23-31; doi.org/10.1016/j.bbagrm.2014.10.004 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | V. C. Sladky et al., Developmental Cell, 2019, 52: 335–349, doi.org/10.1016/j.devcel.2019.12.016 | Link | ||
HepG2.2.15 |
Human hepatoma cell line expressing complete HBV genome | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Zhu et al., Zhonghua Yi Xue Za Zhi, Sep 2005; 85(35): 2503-6 | |||
HepG2.2.15 |
Human hepatoma cell line expressing complete HBV genome | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. Zhu et al., Zhonghua Gan Zang Bing Za Zhi, Sep 2004; 12(9): 522-5 | |||
HGF |
Human gingival fibroblasts | Human | digestive organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Min et al., J. Biochem. Molecular Toxicology, 2015, 29(2): 70-76; DOI 10.1002/jbt | |||
HK-2 |
Human kidney cell line HPV-16 transformed | ATCC CRL-2190 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | Y. Attali-Padael et al., Biol. Cell., 2021, 113: 450–457, DOI: 10.1111/boc.202100011 | Link | ||
HKe-3 |
Human colon carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HKe-3 |
Human colon carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HKe-3 |
Human colon carcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HKe-3 |
Human colon carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HKe-3 |
Human colon carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HMC |
Human mesangial cells | Human | unknown | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | J. L. Cano-Penalver et al., Mol. Med., 2015, 21:873-885; doi: 10.2119/molmed.2015.00059 | Link | ||
hMDM |
Human primary monocyte-derived macrophages | Human | immune system | primary cell | siRNA | RNA-Interference | Metafectene | publication | M. P. Morrow et al., Mol. Pharmacol., Aug 2010; 78: 215 - 225 | Link | |||
hMSC |
Human primary mesenchymal stem cells | Human | unknown | stem cell | adherent | plasmid | RNA-Interference | Metafectene | publication | J. Cheng et al., Wei Sheng Yan Jiu, Sep 2006; 35(5): 564-6. | |||
HOG |
Human oligodendroglial cells | Human | nervous system | unknown | adherent | plasmid | Metafectene | publication | G. Chase et al., J. Virol., Jan 2007; 81: 743 - 749 | Link | |||
HOSE |
Human non-tumorigenic, immortalized ovarian epithelial cells | Human | genital tract | cell line | adherent | plasmid | Metafectene | application note | ![]() |